Cubist Systematic Strategies’s Elevance Health ELV Stock Holding History

Cubist Systematic Strategies’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$8.21M	Buy	25,400 +18,700	+279%	+$5.82M	0.04%	666
2025 Q2	$2.61M	Sell	6,700 -28,400	-81%	-$11.4M	0.01%	1423
2025 Q1	$15.3M	Sell	35,100 -13,900	-28%	-$5.58M	0.09%	296
2024 Q4	$18.1M	Buy	+49,000	New	+$20.5M	0.11%	234
2024 Q3	–	Sell	-300	Closed	-$163K	–	3119
2024 Q2	$163K	Buy	+300	New	+$159K	﹤0.01%	2547
2023 Q3	–	Sell	-900	Closed	-$400K	–	3496
2023 Q2	$400K	Sell	900 -2,100	-70%	-$969K	﹤0.01%	2513
2023 Q1	$1.38M	Buy	3,000 +2,300	+329%	+$1.09M	0.01%	1936
2022 Q4	$359K	Buy	+700	New	+$355K	﹤0.01%	3249

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Cubist Systematic Strategies's ELV Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 221 shares — an estimated $117K sold.

Cubist Systematic Strategies first reported a position in ELV in Q2 2014 and held it in 40 quarters. The position peaked at $74.5M in Q3 2023. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

Cubist Systematic Strategies reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 221 Elevance Health shares in Q2 2024, an estimated $117K.
Cubist Systematic Strategies first reported a position in Elevance Health in Q2 2014 and held it in 40 quarters.
Cubist Systematic Strategies's Elevance Health position peaked at $74.5M in Q3 2023.
1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.